PM
Peter Mark Menezes
About Peter Mark Menezes
Data last updated:
Peter Mark Menezes is an Additional Director at Menezes Pharmaceuticals Limited (since 2025). The company operates in Financial Services. Menezes Pharmaceuticals Limited reported revenue of ₹17.15 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 18 Dec 2025 | ₹17.15 Cr (FY 2025) | Active |
Board colleagues of Peter Mark Menezes
| Name | DIN | Company | Designation |
|---|---|---|---|
| Brenda Juliette Nazareth Menezes | 01126236 | Menezes Pharmaceuticals Limited | Director |
| Christine Stephanie Menezes | 06549798 | Menezes Pharmaceuticals Limited | Nodal Officer |
| Maryann Veronica Menezes | 00145980 | Menezes Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Peter Mark Menezes
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Peter Mark Menezes
Peter Mark Menezes currently holds 1 directorship: Menezes Pharmaceuticals Limited (Additional Director, since 18 Dec 2025, revenue ₹17.15 Cr (FY 2025)).
Peter Mark Menezes was first appointed on 18 Dec 2025 as Additional Director at Menezes Pharmaceuticals Limited.
The current boards of Peter Mark Menezes's companies include Brenda Juliette Nazareth Menezes (Menezes Pharmaceuticals Limited), Christine Stephanie Menezes (Menezes Pharmaceuticals Limited), Maryann Veronica Menezes (Menezes Pharmaceuticals Limited).